Search

Your search keyword '"Phenols -- Intellectual property"' showing total 573 results
Start Over Descriptor "Phenols -- Intellectual property"
573 results on '"Phenols -- Intellectual property"'

3. Patent Application Titled 'Multidose Antibody Drug Products Using Phenol Or Benzyl Alcohol' Published Online (USPTO 20240366471)

Subjects
Biopharmaceutics -- Intellectual property, Viral antibodies, Phenols -- Intellectual property, Backup software -- Intellectual property, Antibodies, Blood proteins, Physical fitness, Backup software, Health
Abstract

2024 NOV 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2024

4. Patent Application Titled 'D3 Dopamine Receptor-Selective Negative Allosteric Modulators' Published Online (USPTO 20240336604)

Subjects
Cardiotonic agents -- Intellectual property, Phenols -- Intellectual property, Cardiac glycosides -- Intellectual property, Physical fitness, Health
Abstract

2024 NOV 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2024

5. Patent Issued for Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer (USPTO 12083112)

Subjects
Intellectual property, Cancer treatment, Women's health, Cancer, Nivolumab, Tyrosine -- Intellectual property, Lenvatinib, Pembrolizumab, Phenols (Class of compounds) -- Intellectual property, Women -- Health aspects, Phenols -- Intellectual property, Cancer -- Care and treatment
Abstract

2024 OCT 3 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Eisai R&D Management Co. Ltd. (Tokyo, Japan) has been issued patent number 12083112, according [...]

Published
2024

7. Patent Application Titled 'Detection And Monitoring Of Dosage Delivery For Vaporized Waxes, Solids Or Viscous Oils, And Cannabinoids' Published Online (USPTO 20240226466)

Subjects
Drugs -- Vehicles, Phenols -- Intellectual property, Cannabinoids, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2024 AUG 3 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2024

10. Researchers Submit Patent Application, 'Small Molecule Degraders Of Estrogen Receptor With Cereblon Ligands', for Approval (USPTO 20240190880)

Subjects
Women -- Health aspects, Biochemistry, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JUL 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Acharyya, [...]

Published
2024

11. Patent Issued for Estrogen receptor modulators (USPTO 11999728)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Bunker, Kevin Duane (Escondido, CA, US), Hegde, Sayee Gajanan [...]

Published
2024

13. Patent Issued for Selective estrogen receptor degraders (USPTO 11993608)

Subjects
Eli Lilly and Co. -- Intellectual property, Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JUN 20 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Eli Lilly and Company (Indianapolis, Indiana, United States) has been issued patent number 11993608, [...]

Published
2024

14. Patent Application Titled 'Therapeutic Targeting Of Receptor Tyrosine Kinase Inhibitor-Induced Androgen Receptor Phosphorylation In Cancer' Published Online (USPTO 20240165078)

Subjects
Women -- Health aspects, Tyrosine -- Intellectual property, Prostate cancer, Nilotinib, Antineoplastic agents -- Intellectual property, Tofacitinib, Phenols -- Intellectual property, Cancer, Antimitotic agents -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JUN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2024

16. Patent Application Titled 'Prediction Of Amount Of In Vivo Dopamine Etc., And Application Thereof' Published Online (USPTO 20240159780)

Subjects
Cardiotonic agents -- Intellectual property, Nervous system diseases, Phenols -- Intellectual property, Cardiac glycosides -- Intellectual property, Physical fitness, Neurophysiology, Health
Abstract

2024 JUN 8 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2024

18. Researchers Submit Patent Application, 'Detection And Monitoring Of Dosage Delivery For Vaporized Waxes, Solids Or Viscous Oils, And Cannabinoids', for Approval (USPTO 20240131281)

Subjects
Drugs -- Vehicles, Phenols -- Intellectual property, Cannabinoids, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2024 MAY 18 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- From Washington, D.C., NewsRx journalists report that a patent application by the [...]

Published
2024

21. Patent Issued for Processes for the preparation of selective estrogen receptor degraders (USPTO 11926634)

Subjects
Eli Lilly and Co. -- Intellectual property, Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Pharmaceutical industry -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 APR 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- A patent by the inventors Arguelles Delgado, Alonso Jose (Indianapolis, IN, US), Czeskis, Boris [...]

Published
2024

22. Patent Issued for Salts of selective estrogen receptor degraders (USPTO 11903931)

Subjects
Women -- Health aspects, Phenols -- Intellectual property, Estrogen, Fulvestrant -- Intellectual property, Health, Women's issues/gender studies, L-Lysine (Dietary supplement) -- Intellectual property
Abstract

2024 MAR 14 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Inventisbio Co. Ltd. (Shanghai, People's Republic of China) has been issued patent number 11903931, [...]

Published
2024

23. Patent Issued for Estrogen therapy for brain gray matter atrophy and associated disability (USPTO 11865122)

Subjects
Women -- Health aspects, Tizanidine -- Intellectual property, Multiple sclerosis, Phenols -- Intellectual property, Estrogen, Health, Women's issues/gender studies
Abstract

2024 FEB 1 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- University of California (Oakland, California, United States) has been issued patent number 11865122, according [...]

Published
2024

24. Patent Issued for Pyrimidines for degrading Bruton's tyrosine kinase (USPTO 12172992)

Subjects
Tyrosine -- Intellectual property, Phenols -- Intellectual property, Pyrimidines -- Intellectual property, Proteins
Abstract

2025 JAN 13 (NewsRx) -- By a News Reporter-Staff News Editor at Hematology Week -- AbbVie Inc. (North Chicago, Illinois, United States) has been issued patent number 12172992, according to [...]

Published
2025

25. Patent Issued for Purification process for removal of tyrosine sulfation antibody variants; purified compositions (USPTO 12162938)

Subjects
Tyrosine -- Intellectual property, Biological products -- Intellectual property, Viral antibodies, Phenols -- Intellectual property, Antibodies, Health
Abstract

2025 JAN 3 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A patent by the inventors Dukleska Schussler, Svetlana (Elmwood Park, NJ, US), Rios, [...]

Published
2025

26. Researchers Submit Patent Application, 'Novel Combination Of Serotonin Receptor (5-Htr2b) Antagonist And An Immunomodulator And Chemotherapeutic Drugs For Inhibition Of Cancer', for Approval (USPTO 20240408071)

Subjects
Biochemistry, Cyproheptadine -- Intellectual property, Phenols -- Intellectual property, Cancer -- Prevention -- Chemotherapy, G proteins, Chemotherapy, Drug approval, Monoclonal antibodies, Business, Health, Health care industry
Abstract

2024 DEC 31 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors KARMAKAR, Surojit [...]

Published
2024

27. Patent Application Titled 'Dopamine D3 Receptor Selective Antagonists/Partial Agonists And Uses Thereof' Published Online (USPTO 20240408084)

Subjects
Cardiotonic agents -- Intellectual property, Opioids, Mental health, Phenols -- Intellectual property, Cardiac glycosides -- Intellectual property
Abstract

2024 DEC 30 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent [...]

Published
2024

30. Researchers Submit Patent Application, 'Polyhydric Phenol Resin, As Well As Resin Composition, Cured Product Thereof, And Use Thereof', for Approval (USPTO 20240400728)

Subjects
Phenols -- Intellectual property, Electronics industry -- Intellectual property, Electronics industry, Electronics
Abstract

2024 DEC 24 (VerticalNews) -- By a News Reporter-Staff News Editor at Electronics Newsweekly -- From Washington, D.C., VerticalNews journalists report that a patent application by the inventors OGURA, Ichiro [...]

Published
2024

31. Researchers Submit Patent Application, 'Whole Plant Cannabis Tea With Bioavailable Cannabinoids', for Approval (USPTO 20240389612)

Subjects
Tea industry -- Intellectual property, Marijuana -- Intellectual property, Phenols -- Intellectual property, Business, Health, MCT Oil (Medication) -- Intellectual property
Abstract

2024 DEC 20 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2024

33. Patent Application Titled 'Dopamine Receptor Agonists Or Angiotensin Receptor Blockers Or Combinations Thereof For Covid-19 Sequelae' Published Online (USPTO 20240382500)

Subjects
Cardiotonic agents -- Intellectual property, Phenols -- Intellectual property, Cardiac glycosides -- Intellectual property, Fenoldopam -- Intellectual property, Telmisartan -- Intellectual property, Angiotensin, Business, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 DEC 9 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2024

35. Patent Application Titled 'Isoxazole Derivatives As Modulators Of The 5-Ht2a Serotonin Receptor Useful For The Treatment Of Disordered Related Thereto' Published Online (USPTO 20240376090)

Subjects
Heart diseases, Phenols -- Intellectual property, Serotonin, Biotechnology industry, Pharmaceuticals and cosmetics industries, Health
Abstract

2024 DEC 8 (NewsRx) -- By a News Reporter-Staff News Editor at Heart Disease Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application [...]

Published
2024

37. Patent Issued for Pet food formulation with cannabinoids (USPTO 12128091)

Subjects
Pet food -- Intellectual property, Phenols -- Intellectual property, Arthritis, Pet supplies industry -- Intellectual property, Mediation, Business, Health
Abstract

2024 NOV 22 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent [...]

Published
2024

38. Patent Application Titled 'Masked Chimeric Antigen Receptor Specific To Tyrosine-Protein Kinase Like 7 (Ptk7) And Immune Cells Expressing Such' Published Online (USPTO 20240352151)

Subjects
Tyrosine -- Intellectual property, T cells, Phenols -- Intellectual property, Antigens, Protein kinases, Genetically modified organisms
Abstract

2024 NOV 12 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2024

39. 'Treatment For Tyrosine Degradation-Associated Disorders' in Patent Application Approval Process (USPTO 20240344072)

Subjects
Genetic aspects, Intellectual property, Cancer treatment, Cancer genetics -- Genetic aspects, Patient compliance, Tyrosine -- Intellectual property -- Genetic aspects, Nitisinone -- Intellectual property, Phenols (Class of compounds) -- Intellectual property, Phenols -- Intellectual property, Cancer -- Care and treatment -- Genetic aspects
Abstract

2024 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A patent application by the inventors Doreste, Bruno (London, GB); Gissen, Paul (London, [...]

Published
2024

40. Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin[TM]

Subjects
Nervous system diseases, Phenols -- Intellectual property, Product development, Time to market, Business, Business, international
Abstract

* U.S. Patent Office issues patent number 12,102,616 * Patent covers the compositions of matter, methods of use and methods of production for Conjugated Psilocin[TM] * Alera Pharma, Inc., (a [...]

Published
2024

41. Patent Issued for Inhibiting agents for bruton's tyrosine kinase (USPTO 11858926)

Subjects
Tyrosine -- Intellectual property, Phenols -- Intellectual property, Proteins, Physical fitness, Health
Abstract

2024 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Biogen MA Inc. (Cambridge, Massachusetts, United States) has been issued patent number [...]

Published
2024

42. Researchers Submit Patent Application, 'Use Of Combined Oral Contraceptives Containing Nomegestrol Acetate And Estradiol', for Approval (USPTO 20230398127)

Subjects
Estradiol -- Intellectual property, Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Contraceptives -- Intellectual property, Acetates -- Intellectual property, Health, Women's issues/gender studies
Abstract

2024 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor BOOLELL, [...]

Published
2024

43. Researchers Submit Patent Application, 'Methods Of Contraception Using Nomegestrol Acetate And Estradiol', for Approval (USPTO 20230390306)

Subjects
Estradiol -- Intellectual property, Women -- Health aspects, Drospirenone -- Intellectual property, Phenols -- Intellectual property, Contraceptives -- Intellectual property, Norgestimate -- Intellectual property, Transdermal medication -- Intellectual property, Acetates -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 DEC 28 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor BOOLELL, [...]

Published
2023

44. Researchers Submit Patent Application, 'Substituted Benzothiophene Analogs As Selective Estrogen Receptor Degraders', for Approval (USPTO 20230381137)

Subjects
Women -- Health aspects, Biochemistry, Thiophene, Antineoplastic agents -- Intellectual property, Phenols -- Intellectual property, Estrogen, Antimitotic agents -- Intellectual property, Health, Women's issues/gender studies
Abstract

2023 DEC 21 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors GUTGESELL, [...]

Published
2023

46. Patent Application Titled 'Estrogen Receptor Beta Ligands For The Prevention And Treatment Of Multiple Sclerosis (Ms) And Other Demyelinating, Inflammatory And Neurodegenerative Diseases' Published Online (USPTO 20230357161)

Subjects
Multiple sclerosis, Phenols -- Intellectual property, Estrogen, Physical fitness, Health
Abstract

2023 DEC 2 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2023

47. New Findings in Cancer Described from Shiraz University of Medical Sciences (A Patent Review On Efficient Strategies for the Total Synthesis of Pazopanib, Regorafenib and Lenvatinib As Novel Anti-angiogenesis Receptor Tyrosine Kinase Inhibitors ...)

Subjects
Tyrosine -- Intellectual property, Antineoplastic agents -- Intellectual property, Phenols -- Intellectual property, Organic compounds -- Synthesis, Cancer, Physical fitness, Antimitotic agents -- Intellectual property, Health
Abstract

2023 NOV 4 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Researchers detail new data in Cancer. According to news reporting originating from [...]

Published
2023

49. Researchers Submit Patent Application, 'Serotonin 5-HT2A, 5-HT2B, and 5-HT2C Receptor Inverse Agonists', for Approval (USPTO 20240327353)

Subjects
Chloroprocaine -- Intellectual property, Mental health, Schizophrenia, Phenols -- Intellectual property, Anxiety, Serotonin, Health, Psychology and mental health
Abstract

2024 OCT 21 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results